ERBB2 and breast cancer: Furthermore, peritumoral radiomics features can provide insights into the biological characteristics and pathological responses of HER2-positive breast cancer to preoperative targeted therapy by detecting biological information related to lymphocytic spatial structure, vascular invasion, and the immune response of surrounding breast tissue (39).